Fixed-dose combination antituberculosis therapy as a risk factor for tuberculosis recurrence: an evidence-based case report

Fixed-dose combination antituberculosis therapy as a risk factor for tuberculosis recurrence: an evidence-based case report

Background: a patient with a history of tuberculosis (TB) has a risk up to 27% to develop recurrence within 2 years after being cured. Indonesia itself has more than 7,500 recurrent cases annually, regardless of reinfection or relapse. This is an important problem, as recurrent TB is associated with...

Полное описание

Библиографические подробности
Главные авторы:	Arvin Pramudita, Cleopas M Rumende, Ardi Findyartini
Формат:	Статья
Язык:	English
Опубликовано:	Interna Publishing 2017-04-01
Серии:	Acta Medica Indonesiana
Предметы:	tuberculosis fixed-dose combination recurrent
Online-ссылка:	http://www.actamedindones.org/index.php/ijim/article/view/327

Схожие документы

Treating more with less: Effectiveness and event outcomes of antituberculosis fixed-dose combination drug versus separate-drug formulation (Ethambutol, Isoniazid, Rifampicin and Pyrazinamide) for pulmonary tuberculosis patients in real-world clinical practice
по: Jacqueline Mui Lan Lai, и др.
Опубликовано: (2019-01-01)

Relative Bioavailability of Rifampicin in Four Chinese Fixed-dose Combinations Compared with Rifampicin in Free Combinations
по: Hui Zhu, и др.
Опубликовано: (2015-01-01)

Comparison of the safety and efficacy of a fixed-dose combination regimen and separate formulations for pulmonary tuberculosis treatment
по: Jiun-Ting Wu, и др.
Опубликовано: (2015-06-01)

In vitro antimicrobial efficacy of a fixed-dose combination of RHZE against M. tuberculosis
по: Vanessa Albertina Agertt, и др.

Potential side effects of medicine on patients with tuberculosis fixed-dose combination in dr. Pirngadi Hospital, Medan
по: EVA SARTIKA DASOPANG, и др.
Опубликовано: (2020-02-01)

Comparison of sputum conversion time in tuberculosis treatment with fix-dose combination drugs and separate drug regimens
по: Soheila Khodakarim, и др.
Опубликовано: (2020-01-01)

Treatment outcome in smear-positive pulmonary tuberculosis patients treated with a fixed-dose drug combination regimen in comparison with a separate regimen: a randomized clinical trial
по: Seyed Saeed Hashemi Nazari, и др.
Опубликовано: (2021-01-01)

Experience of Fixed-Dose Combinations of Anti-Tuberculosis Drugs for Preventive Treatment in Children
по: O. D. Baronova, и др.
Опубликовано: (2023-12-01)

Optimization of Hypertension Treatment using Fixed-Dose Combination of Perindropril/Amlodipine
по: Evan Hindoro, и др.
Опубликовано: (2015-12-01)

Fixed dosed combinations in the treatment of hypertension
по: Gabriel Hancu, и др.
Опубликовано: (2020-03-01)

Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects
по: A. L. Khokhlov, и др.
Опубликовано: (2022-05-01)

Assessment of treatment outcomes of daily fixed-dose combination therapy among drug-sensitive pulmonary tuberculosis patients: A prospective study from Bengaluru, India
по: M Sumana, и др.
Опубликовано: (2024-07-01)

Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis
по: Paweł Kawalec, и др.
Опубликовано: (2018-08-01)

From combined therapy to fixed-dose combinations
по: I. P. Kolos, и др.
Опубликовано: (2008-08-01)

A promising choice in hypertension treatment: Fixed-dose combinations
по: Xinhuan Wan, и др.
Опубликовано: (2014-02-01)

Fixed-dose versus separate drug combinations for antihypertensive treatment: literature review
по: José Luis Calleja Rivero
Опубликовано: (2016-09-01)

Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar
по: Mohammad H. Al-Shaer, и др.
Опубликовано: (2018-08-01)

Therapy compliance and fixed-dose combinations in arterial hypertension treatment. Focus on a fixed-dose combination of felodipine and metoprolol
по: S. A. Shalnova, и др.
Опубликовано: (2009-12-01)

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
по: Tarantino N, и др.
Опубликовано: (2017-02-01)

The Roll-out of Child-friendly Fixed-dose Combination TB Formulations in High-TB-Burden Countries: A Case Study of STEP-TB
по: Lena Faust, и др.
Опубликовано: (2019-08-01)

Modern antihypertensive therapy: the effectiveness of a unique Russian fixed-dose combination of ramipril and indapamide
по: A. O. Konradi, и др.
Опубликовано: (2020-04-01)

Critical Analysis of Cardiovascular and Central Nervous System Fixed Dose Combinations Available in Indian Market
по: Krunal Prajapati, и др.
Опубликовано: (2016-12-01)

Fixed-dose combinations in the treatment of hypertension to increase adherence
по: T. E. Morozova, и др.
Опубликовано: (2020-12-01)

A cost-minimization analysis of combination therapy in hypertension: fixed-dose vs extemporary combinations
по: Marco Bellone, и др.
Опубликовано: (2013-12-01)

Sitagliptin/metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy
по: Hayes J, и др.
Опубликовано: (2016-07-01)

Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men
по: Choi HK, и др.
Опубликовано: (2016-10-01)

Enhanced Stability and Compatibility of Montelukast and Levocetirizine in a Fixed-Dose Combination Monolayer Tablet
по: Tae Han Yun, и др.
Опубликовано: (2024-07-01)

The use of capillary electrophoresis in the simultaneous determination of fixed-dose combination drugs for cardiovascular diseases
по: Gabriel Hancu, и др.
Опубликовано: (2020-09-01)

Regulatory requirements for marketing fixed dose combinations
по: B G Jayasheel
Опубликовано: (2010-01-01)

Clinical use of a fixed-dose combination of telmisartan and indapamide in hypertension. Expert Council resolution
по: A. O. Konradi, и др.
Опубликовано: (2025-02-01)

Clinical Benefit of Fixed‐Dose Combination of Amlodipine and Potent Atorvastatin in Patients With Concomitant Hypertension and Hypercholesterolemia
по: Chia‐Pin Lin, и др.
Опубликовано: (2024-05-01)

Capillary electrophoresis for the assay of fixed-dose combination tablets of artesunate and amodiaquine
по: Amin N’Cho, и др.
Опубликовано: (2012-05-01)

Efficacy of a fixed dose combination of irbesartan and atorvastatin (Rovelito®) in Korean adults with hypertension and hypercholesterolemia
по: Ihm SH, и др.
Опубликовано: (2019-02-01)

The Adherence to Fixed-Dose Combination Antiretroviral Therapy and Viral Load in HIV Patients
по: Salma Auliannissa, и др.
Опубликовано: (2020-01-01)

LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review
по: Rogliani P, и др.
Опубликовано: (2018-10-01)

From Scylla to Charybdis: Fixed drug combinations for tuberculosis and increased ethambutol-induced optic neuropathy in India
по: Archana Bhargava, и др.
Опубликовано: (2022-01-01)

Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers
по: Oh M, и др.
Опубликовано: (2017-12-01)

Triple fixed-dose combination in the treatment of hypertension: the results of the Russian observational study TRICOLOR
по: Yu. A. Karpov, и др.
Опубликовано: (2020-11-01)

The analysis of the availability of fixed-dose combinations in antiretroviral therapy for HIV infection in the Russian Federation
по: Elena A. Pyadushkina, и др.
Опубликовано: (2021-12-01)

IMPACT OF THE FORM OF MEDICATION ON TREATMENT ADHERENCE IN RESPIRATORY TUBERCULOSIS PATIENTS
по: T. E. Tyulkova, и др.
Опубликовано: (2018-01-01)